|
|
|
02.04.26 - 22:06
|
CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026 (Business Wire)
|
|
|
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.
This conference call will also be webcast and can be accessed from the “Investors” section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, and thoracic surgery. For more information, visit...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28.01.26 - 22:06
|
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results (Business Wire)
|
|
|
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025.
Fourth Quarter 2025 Highlights
Sales of $373.2 million increased 7.9% year-over-year as reported and 7.1% in constant currency.
Domestic revenue increased 1.4% year-over-year.
International revenue increased 17.0% year-over-year as reported and 15.4% in constant currency.
Diluted net earnings per share (GAAP) were $0.54, compared to diluted net earnings per share (GAAP) of $1.08 in the fourth quarter of 2024.
Adjusted diluted net earnings per share(1) were $1.43, compared to adjusted diluted net earnings per share of $1.34 in the fourth quarter of 2024.
Full-Year 2025 Highlights
Sales of $1,374.7 million increased 5.2% year-over-year as reported and 5.1% in constant currency.
Domestic revenue increased 3.5% year-over-year.
International revenue increased 7.4% year-over-year as reported and 7.1% in constant currency.
Diluted net earnings per share (GA...
|
|
|
|
|
08.01.26 - 22:57
|
CONMED Corporation Announces Chief Financial Officer Transition (Business Wire)
|
|
|
Todd Garner to step down as CONMED's CFO, effective March 15, 2026, and remain In an Advisory Role Through November 2, 2026
Company Initiates Comprehensive Search for Next Chief Financial Officer
CONMED Reaffirms Full-Year 2025 Revenue and Adjusted EPS OutlookLARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and orderly transition, Mr. Garner will remain with the Company in an advisory capacity through November 2, 2026.
CONMED has initiated a comprehensive search process, supported by a leading executive search firm, to identify its next Chief Financial Officer.
“On behalf of our Board and leadership team, I want to thank Todd for his many contributions to CONMED over the past eight years,” said Pat Beyer, President and Chief Executive Officer. “Todd has been instrumental in strengthening our financial foundation and supporting strategic initiatives that pos...
|
|
|
05.01.26 - 22:06
|
CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026 (Business Wire)
|
|
|
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2025 after the market close on Wednesday, January 28, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.
This conference call will also be webcast and can be accessed from the “Investors” section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, and thoracic surgery. For more information, vi...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
